Clofazimine

85 interactions 7 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Clofazimine Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Clofazimine Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Clofazimine Sertraline Explained An increased risk of QT interval prolongation Details Clofazimine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation, increased buprenorphine exposure and an increased risk of buprenorphine-related adv... Details Clofazimine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Clofazimine Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Clofazimine Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Clofazimine Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Clofazimine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Clofazimine Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Clofazimine Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Clofazimine Avapritinib Ayvakit Increased avapritinib exposure and an increased risk of the incidence and severity of adverse reactions Details Clofazimine Azithromycin AzaSite An increased risk of QT interval prolongation Details Clofazimine Cariprazine Vraylar Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Clofazimine Alfuzosin UroXatral An increased risk of QT interval prolongation Details Clofazimine Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Clofazimine Anagrelide Agrylin An increased risk of QT interval prolongation Details Clofazimine Bedaquiline Sirturo Increased bedaquiline exposure and an increased risk of QT interval prolongation Details Clofazimine Bosutinib Bosulif Increased bosutinib exposure Details Clofazimine Brexpiprazole Rexulti Increased brexpiprazole exposure Details Clofazimine Budesonide Entocort Increased budesonide exposure Details Clofazimine Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Clofazimine Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Clofazimine Chloroquine Aralen® An increased risk of QT interval prolongation Details Clofazimine Cyclosporine Injection Atopica Increased cycloSPORINE exposure Details Clofazimine Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure Details Clofazimine Dasatinib Phyrago An increased risk of QT interval prolongation Details Clofazimine Degarelix Injection Firmagon An increased risk of QT interval prolongation Details Clofazimine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Clofazimine Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clofazimine Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clofazimine Disopyramide Norpace An increased risk of QT interval prolongation Details Clofazimine Dofetilide Tikosyn An increased risk of QT interval prolongation Details Clofazimine Dolasetron Anzemet An increased risk of QT interval prolongation Details Clofazimine Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Clofazimine Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Clofazimine Encorafenib Braftovi Increased encorafenib exposure, an increased risk of encorafenib-related adverse reactions and an increased risk of QT interval pr... Details Clofazimine Entrectinib Rozlytrek Increased entrectinib exposure, an increased frequency or severity of adverse reactions including increased risk of cardiac arrhyt... Details Clofazimine Eribulin Injection Halaven An increased risk of QT interval prolongation Details Clofazimine Famotidine Calmicid An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.